drugset / Trial / NCT01900249
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether 0.2% and 0.5% R348 Ophthalmic Solutions are safe and effective in the treatment of Patients with Keratoconjunctivitis Sicca.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | R348 | Small molecule | 0.2 % | Other |
| Comparator | R348 | Small molecule | 0.5 % | Other |